Lombard Odier Transatlantic’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q1
Sell
-700
Closed -$114K 126
2015
Q4
$114K Hold
700
0.1% 67
2015
Q3
$97K Hold
700
0.1% 57
2015
Q2
$107K Sell
700
-6,900
-91% -$1.11M 0.09% 66
2015
Q1
$1.22M Buy
7,600
+700
+10% +$110K 0.95% 36
2014
Q4
$1.1M Buy
+6,900
New +$1.08M 1.01% 32

Other funds holding AMGN

Lombard Odier Transatlantic's AMGN Position: Q1 2016 in Review

Lombard Odier Transatlantic sold out of Amgen (AMGN) in Q1 2016, closing a stake of 700 shares — an estimated $114K sold.

Lombard Odier Transatlantic first reported a position in AMGN in Q4 2014 and held it in 5 quarters. The position peaked at $1.22M in Q1 2015. 1,434 funds tracked by Wall St. Rank hold AMGN as of Q1 2016.

  • Lombard Odier Transatlantic reported no remaining Amgen position as of Q1 2016 after selling out during the quarter.
  • Lombard Odier Transatlantic sold 700 Amgen shares in Q1 2016, an estimated $114K.
  • Lombard Odier Transatlantic first reported a position in Amgen in Q4 2014 and held it in 5 quarters.
  • Lombard Odier Transatlantic's Amgen position peaked at $1.22M in Q1 2015.
  • 1,434 funds tracked by Wall St. Rank held Amgen as of Q1 2016.

Based on Lombard Odier Transatlantic's 13F filing for Q1 2016, filed 17 May 2016.